Summary
This security clearance application was denied under Guideline H (Drug Involvement) due to the applicant's admitted misuse of prescription medication. The applicant, representing himself, acknowledged misusing prescription drugs from June 2017 to August 2020, a period that included time when he held a security clearance.
The judge found that the applicant's drug abuse constituted a disqualifying condition under AG ¶ 25. The denial was based on several factors: the significant duration of the applicant's admitted prescription medication misuse, insufficient evidence to assure that the drug abuse would not recur, and the applicant's failure to provide a signed statement of intent to abstain from future drug involvement.
The appeal board affirmed the judge's decision, concluding that the applicant did not demonstrate that the initial denial was arbitrary or capricious. Consequently, the security clearance application was denied.
Conditions Referenced
- AG ¶ 25raisedDrug Involvement
Key Rule Quoted
“The general standard is that a clearance may be granted only when ‘clearly consistent with national security.’”
Procedural Posture
- SOR issuedJan 5, 2021
- Answer filed—Applicant requested a decision on the written record.
- Hearing heldJul 27, 2021
- Decision dateOct 14, 2021Decision affirmed on appeal.
Cite For
- Affirmation of Adverse Decisions Based on Drug Involvement Under Guideline H
- Importance of Providing Evidence of Rehabilitation in Security Clearance Cases
- Limitations on Introducing New Evidence During the Appeal Process